Recent studies suggested that additional mutations in ABCB11 may be associated with various disease processes such as benign recurrent intrahepatic cholestasis (BRIC), intrahepatic cholestasis of pregnancy (ICP), and risk for drug-induced cholestasis (DC) [33–36]. This evidence concerns the gene ABCB11 and benign recurrent intrahepatic cholestasis.